SynthesisInfectious diseases of poverty2020
China's practice to prevent and control COVID-19 in the context of large population movement.
Synthesis in Infectious diseases of poverty, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis.Frontiers in medicine · 2023Pooled it
- Effective public health measures to mitigate the spread of COVID-19: a systematic review.BMC public health · 2021Pooled it
- Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.The Journal of hospital infection · 2021Pooled it
- A systematic review of the case findings, testing and management of COVID-19.F1000Research · 2021Pooled it
- Systematic prediction of spatiotemporal transmission of potential respiratory pandemics in China.Infectious Disease Modelling · 2026Article
- Retrospective estimate of COVID-19 infections in nine Colombian cities in 2020.Epidemiology and infection · 2026Article
- Impact of nonpharmaceutical interventions on inflammatory diseases of the nose.Annals of medicine · 2025Article
- Distance Learning During the COVID-19 Lockdown and Self-Assessed Competency Development Among Radiology Residents in China: Cross-Sectional Survey.JMIR medical education · 2025Article
- Quantitative assessment of Public Health and Social Measures implementation and relaxation on influenza transmission during COVID-19 in China: SEIABR and GBDT models.Journal of global health · 2024Article
- Weak Value Amplification Based Optical Sensor for High Throughput Real-Time Immunoassay of SARS-CoV-2 Spike Protein.Biosensors · 2024Article
- Article
- Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China.Frontiers in public health · 2023Article
- Impact of COVID-19 on health services utilization in mainland China and its different regions based on S-ARIMA predictions.PLOS global public health · 2023Article
- The impact of COVID-19 on employment and income of vocational graduates in China: Evidence from surveys in January and July 2020.China economic review · 2022Article
- Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic.Medical journal, Armed Forces India · 2022Article
- Why they willingly complied: Ordinary people, the big environment, and the control of COVID-19 in China.Social science & medicine (1982) · 2022Article
- Impact of COVID-19 on paediatric admissions to a Chinese hospital: a single-centre retrospective chart review.BMJ open · 2022Article
- Assessing work resumption in hospitals during the COVID-19 epidemic in China using multiscale geographically weighted regression.Transactions in GIS : TG · 2022Article
- Which Matters More in Fighting COVID-19-Government Policy or Community Participation?Frontiers in public health · 2022Article
- Analyzing COVID-19 Vaccination Behavior Using an SEIRM/V Epidemic Model With Awareness Decay.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emerging infectious disease, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a serious threat in China and worldwide. Challenged by this serious situation, China has taken many measures to contain its transmission. This study aims to systematically review and record these special and effective practices, in hope of benefiting for fighting against the ongoing worldwide pandemic.
methodsThe measures taken by the governments was tracked and sorted on a daily basis from the websites of governmental authorities (e.g. National Health Commission of the People's Republic of China). And the measures were reviewed and summarized by categorizations, figures and tables, showing an ever-changing process of combating with an emerging infectious disease. The population shift levels, daily local new diagnosed cases, daily mortality and daily local new cured cases were used for measuring the effect of the measures.
resultsThe practices could be categorized into active case surveillance, rapid case diagnosis and management, strict follow-up and quarantine of persons with close contacts, and issuance of guidance to help the public understand and adhere to control measures, plus prompt and effective high-level policy decision, complete activation of the public health system, and full involvement of the society. Along with the measures, the population shift levels, daily local new diagnosed cases, and mortality were decreased, and the daily local new cured cases were increased in China.
conclusionsChina's practices are effective in controlling transmission of SARS-CoV-2. Considering newly occurred situations (e.g. imported cases, work resumption), the control measures may be adjusted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.